Pray S
Hosp Pharm. 1979 Feb;14(2):66, 68, 70-1.
This article discusses a quality assurance procedure to prevent defects that have been discovered in unit-of-use packages supplied by manufacturers from being dispensed and administered. Defects are illustrated in Figs. 1 through 8. Defects are classified as one of three types: multiples of number, defects of omission, and unusual defects. Multiples of number are defined as defects in which medication in excess of the intended number of dosage units is in the package. In defects of omission, the package is partially or totally empty. finally, the unusual defects include those not falling in either of the other groups. While the defect of omission is found to be the most common, the defect with the most potential for causing patient harm is the multiple of number type. The manufacturer could lessen the possibility that the multiple of number might cause patient injury by stating the number of dosage units on the package. An ongoing program of inspection of packages at time of opening them is recommended. When defects are discovered, the manufacturer should be promptly notified.
本文讨论了一种质量保证程序,以防止制造商提供的即用型包装中已发现的缺陷产品被分发和使用。缺陷情况见图1至图8。缺陷分为三种类型之一:数量倍数缺陷、遗漏缺陷和异常缺陷。数量倍数缺陷定义为包装中药物剂量单位超过预期数量的缺陷。在遗漏缺陷中,包装部分或完全为空。最后,异常缺陷包括不属于其他两类的缺陷。虽然遗漏缺陷是最常见的,但最有可能对患者造成伤害的缺陷是数量倍数类型。制造商可以通过在包装上标明剂量单位数量来降低数量倍数缺陷可能导致患者受伤的可能性。建议在打开包装时持续进行检查。发现缺陷时,应及时通知制造商。